Table 2 Validation cohort 1: clinical characteristics of patients for tissue microarray experiment
Patients | Number (%) | |
|---|---|---|
Number | 170 | |
Age (years), mean (range) | 52 (39–93) | |
Histology | Serous | 150 (88.2) |
Non serous | 20 (11.8) | |
Stage | I | 7 (4.1) |
II | 11 (6.4) | |
III | 129 (72.9) | |
IV | 21 (12.3) | |
Grade | 1 | 6 (3.5) |
2 | 22 (12.9) | |
3 | 136 (80) | |
Chemotherapy | Neo-adjuvant | 85 (50) |
Adjuvant | 85 (50) | |
Residual disease | ≤1 cm | 87 (51.2) |
≥1 cm | 57 (33.5) | |
Not determined | 26 (15.3) | |
Response | Responsive | 123 (72.3) |
Resistant | 47 (27.7) | |
Recurrence | Number | 128 (75.3) |
Mean time (range) | 20 months (2–76) | |
Deceased | Number | 105 (61.8) |
Mean time (range) | 47 months (2–156) | |
Follow up | Mean time (range) | 43 months (2–73) |